We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.04B
AUM Growth
-$14.7M
Cap. Flow
-$95.6M
Cap. Flow %
-9.17%
Top 10 Hldgs %
20.32%
Holding
1,067
New
108
Increased
299
Reduced
450
Closed
137

Top Buys

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$7.89M
2
NDMO icon
Nuveen Dynamic Municipal Opportunities Fund
NDMO
+$5.1M
3
GLD icon
SPDR Gold Trust
GLD
+$3.32M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.53M
5
TSLA icon
Tesla
TSLA
+$1.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.5M
2
LULU icon
lululemon athletica
LULU
+$5.75M
3
AMZN icon
Amazon
AMZN
+$4.19M
4
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$3.75M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Healthcare 9.62%
3 Consumer Discretionary 9.35%
4 Financials 7.91%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLMT icon
876
Calumet Specialty Products
CLMT
$3.61B
$51K ﹤0.01%
19,837
– –
FAX
877
abrdn Asia-Pacific Income Fund
FAX
$593M
$50K ﹤0.01%
2,097
-487
-19% -$11.7K
LQDA icon
878
Liquidia Corp
LQDA
$7.55B
$50K ﹤0.01%
+10,200
New +$59K
AMRN
879
Amarin Corp
AMRN
$290M
$49K ﹤0.01%
583
-400
-41% -$47.9K
DBRG icon
880
DigitalBridge
DBRG
$2.93B
$49K ﹤0.01%
4,513
-558
-11% -$5.4K
PHAS
881
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$49K ﹤0.01%
13,865
+2,465
+22% +$9.93K
IRD
882
Opus Genetics
IRD
$287M
$48K ﹤0.01%
5,825
+1,825
+46% +$17.8K
GALT icon
883
Galectin Therapeutics
GALT
$217M
$47K ﹤0.01%
17,498
-3,000
-15% -$8.4K
NYMX
884
DELISTED
Nymox Pharmaceutical Corp
NYMX
$47K ﹤0.01%
19,100
-12,500
-40% -$36.4K
GASS icon
885
StealthGas
GASS
$330M
$46K ﹤0.01%
15,600
– –
GLMD icon
886
Galmed Pharmaceuticals
GLMD
$4.1M
$46K ﹤0.01%
+72
New +$58.8K
XTIA icon
887
XTI Aerospace
XTIA
$57.3M
– –
0
– –
SNGX icon
888
Soligenix
SNGX
$5.34M
$45K ﹤0.01%
105
+36
+52% +$17.8K
RNTX
889
Rein Therapeutics
RNTX
$64.5M
$45K ﹤0.01%
+1,750
New +$41.2K
MBII
890
DELISTED
Marrone Bio Innovations, Inc.
MBII
$45K ﹤0.01%
+37,129
New +$45.1K
ATHX
891
DELISTED
Athersys, Inc. Common Stock
ATHX
$43K ﹤0.01%
+888
New +$53.7K
CREX icon
892
Creative Realities
CREX
$40.1M
$42K ﹤0.01%
+14,273
New +$75.3K
EYPT icon
893
EyePoint Inc
EYPT
$1B
$42K ﹤0.01%
+8,150
New +$51.1K
VTVT icon
894
vTv Therapeutics
VTVT
$119M
$39K ﹤0.01%
550
+35
+7% +$3.08K
SIEN
895
DELISTED
Sientra, Inc.
SIEN
$39K ﹤0.01%
1,150
– –
ZYNE
896
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$39K ﹤0.01%
+11,900
New +$43.7K
RGLS
897
DELISTED
Regulus Therapeutics
RGLS
$36K ﹤0.01%
7,020
+4,962
+241% +$32.7K
TRT
898
Trio-Tech International
TRT
$98.4M
$36K ﹤0.01%
20,818
– –
ALNA
899
DELISTED
Allena Pharmaceuticals
ALNA
$36K ﹤0.01%
24,150
-25,000
-51% -$35.1K
OPGN
900
DELISTED
OpGen, Inc
OPGN
$35K ﹤0.01%
83
-102
-55% -$45.4K
34 35
36
37 38

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Wedbush Securities held 1,067 positions worth $1.04B, down 1.4% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Wedbush Securities withdrew a net $95.6M in Q3 2020, closing 137 positions and reducing 450 holdings. Its most notable exit was Invesco KBW High Dividend Yield Financial ETF, an estimated $810K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Wedbush Securities opened a new position in Nuveen Dynamic Municipal Opportunities Fund worth $5.08M.

  • Wedbush Securities's largest Q3 2020 buy was Nuveen Dynamic Municipal Opportunities Fund: 339,000 shares worth $5.08M.
  • Wedbush Securities added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2020, an estimated $7.89M increase.
  • Wedbush Securities's biggest Q3 2020 reduction was Apple, cutting an estimated $16.5M.
  • Wedbush Securities fully exited Invesco KBW High Dividend Yield Financial ETF in Q3 2020, selling an estimated $810K.
  • Wedbush Securities's ten largest holdings make up 20% of its $1.04B portfolio in Q3 2020.
  • Wedbush Securities opened 108 new positions and closed 137 in Q3 2020.
  • Wedbush Securities's portfolio value fell 1.4% quarter-over-quarter to $1.04B.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.